Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
129,848,689
-
Share change
-
+3,963,533
-
Total reported value
-
$434,588,981
-
Put/Call ratio
-
111%
-
Price per share
-
$3.35
-
Number of holders
-
189
-
Value change
-
+$13,867,107
-
Number of buys
-
90
-
Number of sells
-
84
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q3 2016
As of 30 Sep 2016,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,848,689 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, ACADIAN ASSET MANAGEMENT LLC, MACKENZIE FINANCIAL CORP, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Robeco Institutional Asset Management B.V., and NORTHERN TRUST CORP.
This page lists
189
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.